[PLX] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
07-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -156.82%
YoY- 38.26%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 3,064 3,968 48 5,390 26,113 3,728 2,362 18.96%
PBT -6,837 -4,321 968 -5,479 22 0 968 -
Tax 0 0 -1,741 -81 -8,765 -161 -27,616 -
NP -6,837 -4,321 -9,877 -5,479 9,642 -5,904 -8,913 -16.21%
Tax Rate - - 179.86% - 39,840.91% - 2,852.89% -
Total Cost 9,901 8,289 9,925 10,869 16,471 9,632 11,275 -8.30%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin -223.14 -108.90 -20,577.08 -101.65 36.92 -158.37 -377.35 -29.57%
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS -0.07 -0.05 -1.07 -0.06 0.11 -0.07 -1.01 -83.15%
EPS Diluted -0.07 -0.05 -1.07 -0.06 0.10 -0.07 -1.01 -83.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.